Tumor necrosis factor alpha positive CD4-positive T cell

The term "Tumor necrosis factor alpha positive CD4-positive T cell" refers to a functional subset of "CD4-positive T cells" that produce the cytokine tumor necrosis factor alpha (TNF-alpha). However, this is not a canonical molecular target or receptor; rather, it describes an immune phenotype—specifically, helper T cells that are activated and secrete TNF-alpha as part of their effector function. "CD4-positive T cells", also known as "T helper cells", are central regulators in the adaptive immune system. They assist other immune cells by releasing cytokines such as TNF-alpha and interferon gamma. These cytokines modulate inflammation and coordinate responses against pathogens or tumors. The ability to produce TNF-alpha is one aspect of their activation state and can be relevant in disease contexts such as infection (e.g., COVID-19), autoimmunity (e.g., type 1 diabetes), cancer immunology, and chronic inflammatory diseases. There is no single "receptor" or "target molecule" called "tumor necrosis factor alpha positive CD4-positive T cell." Instead, this phrase identifies a population of immune cells based on both surface marker expression (CD4) and functional status (TNF-alpha production). Drugs like anti-TNF agents may affect these populations indirectly by blocking TNF signaling but do not directly target this composite entity. Because the query combines a functional marker with a cellular identity rather than specifying a unique molecular target or receptor suitable for drug targeting or structural annotation—and because it does not correspond to an established therapeutic target—the entry should be flagged as incorrect for structured database purposes.

Other names

T helper cellTh cellCD4+ lymphocytehelper T lymphocyteCD4-positive lymphocyteTNF-alpha-producing CD4+ T cellTNF-alpha+ Th cell